Abstract
A new capillary electrophoresis (CE) method was presented for the determination of asenapine, an atypical antipsychotic drug, in pharmaceuticals. Box-Behnken design, an experimental design method, was used to investigate the effects of run buffer pH, run buffer concentration and applied potential on the separation of asenapine and granisetron (IS). The optimum conditions were phosphate buffer (15 mM, pH: 3.1) with 25.7 kV voltage and 20 ℃ capillary temperature. The method was validated according to ICH guideline. A good linearity was obtained in the concentration range of 0.27–6.4 µg/mL with LOD and LOQ values of 0.07 and 0.24 μg/mL, respectively. The precision and accuracy of the method were satisfying with intra and interday recovery values of 97.8–100.8% and RSD less than 2%. The proposed CE method was applied to asenapine tablets successfully, for the first time.
Graphical abstract
Similar content being viewed by others
References
Ahuja S (2011) Overview of capillary electrophoresis in pharmaceutical analysis. In: Ahuja S, Jimidar MI (eds) Capillary Electrophoresis methods for pharmaceutical analysis. Academic Press, USA, pp 1–8
Aneesh TP, Rajasekaran A (2012) Stress degradation studies and development and validation of RP-HPLC method for the estimation of asenapine maleate. Int J Pharm Pharm Sci 4(4):448–451
Ansermot N, Brawand-Amey M, Kottelat A, Eap CB (2013) Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring. J Chromatogr A 1292:160–172. https://doi.org/10.1016/j.chroma.2012.12.071
Bizzotto CS, Meinhart AD, Ballus CA, Ghiselli G, Godoy HT (2013) Comparison of capillary electrophoresis and high performance liquid chromatography methods for caffeine determination in decaffeinated coffee. Food Sci Technol 33(1):186–191. https://doi.org/10.1590/S0101-20612013005000013
de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H (2012a) Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects. Biomed Chromatogr 26(2):156–165. https://doi.org/10.1002/bmc.1640
de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H (2012b) Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine. Biomed Chromatogr 26(12):1461–1463. https://doi.org/10.1002/bmc.2722
Borkar AA, Gaikwad NJ (2016) UV spectrophotometric and RP-HPLC estimation of drug asenapine in tablet dosage form. Int J Pharm Sci Res 7(7):3080–3084. https://doi.org/10.13040/IJPSR.0975-8232.7(7).3080-84
Chhalotiya UK, Bhatt KK, Shah DA, Patel JR (2012) Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation. Sci Pharm 80(2):407–417. https://doi.org/10.3797/scipharm.1112-07
Citrome L (2014) Asenapine review, part II: clinical efficacy, safety and tolerability. Expert Opin Drug Saf 13(6):803–830. https://doi.org/10.1517/14740338.2014.908183
Gonzalez JM, Thompson PM, Moore TA (2011) Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder. Patient Prefer Adher 5:333–341. https://doi.org/10.2147/PPA.S10968
Govindarajan N, Koulagari S, Methuku A, Podhuturi S, Venkata RB (2012) Method development and validation of RP-HPLC method for determination of new antipsychotic agent asenapine maleate in bulk and in pharmaceutical formulation. Der Pharmacia Lettre 4(6):1805–1810
Hanrahan G, Montes R, Gomez FA (2008) Chemometric experimental design based optimization techniques in capillary electrophoresis: a critical review of modern applications. Anal Bioanal Chem 390:169–179. https://doi.org/10.1007/s00216-007-1619-y
Hempel G (2000) Strategies to improve the sensitivity in capillary electrophoresis for the analysis of drugs in biological fluids. Electrophoresis 21:691–698. https://doi.org/10.1002/(SICI)1522-2683(20000301)21:4<691:AID-ELPS691>3.0.CO;2-U
Hibbert DB (2012) Experimental design in chromatography: a tutorial review. J Chromatogr B Analyt Technol Biomed Life Sci 910:2–13. https://doi.org/10.1016/j.jchromb.2012.01.020
ICH (2005) International Conference on Harmonization. Guideline Q2(R1): Validation of analytical procedures. https://www.ich.org/products/guidelines/quality/quality-single/article/analytical-procedure-development-and-revision-of-q2r1-analytical-validation-copy-1.html. Accessed 15 April 2019
Jancic-Stojanovic B, Malenovic A, Ivanovic D, Rakic T, Medenica M (2009) Chemometrical evaluation of ropinirole and its impurity’s chromatographic behavior. J Chromatogr A 1216(8):1263–1269. https://doi.org/10.1016/j.chroma.2008.10.059
Karaca SA, Ugur DY (2017) A stability indicating ion-pair LC method for the determination of asenapine in pharmaceuticals. J Chil Chem Soc 62(1):3325–3329. https://doi.org/10.4067/S0717-97072017000100004
Kašicka V (2020) Recent developments in capillary and microchip electroseparations of peptides (2017–mid 2019). Electrophoresis 41:10–35. https://doi.org/10.1002/elps.201900269
Kovatsi L, Titopoulou A, Tsakalof A, Samanidou V (2015) HPLC analysis of antipsychotic asenapine in alternative biomatrices: hair and nail clippings. J Liq Chrom Relat Tech 38(18):1666–1670. https://doi.org/10.1080/10826076.2015.1089894
Managuli RS, Kumar L, Chonkar AD, Shirodkar RK, Lewis S, Koteshwara KB, Reddy MS, Mutalik S (2016) Development and validation of a stability-indicating rp-hplc method by a statistical optimization process for the quantification of asenapine maleate in lipidic nanoformulations. J Chromatogr Sci 54(8):1290–1300. https://doi.org/10.1093/chromsci/bmw062
Mason RL, Gunst RF, Hess JL (2003) Linear regression with several predictor variables. statistical design and analysis of experiments. Wiley, New York, pp 496–534
Miller C, Pleitez O, Anderson D, Mertens-Maxham D, Wade N (2013) Asenapine (Saphris (R)): GC-MS method validation and the postmortem distribution of a new atypical antipsychotic medication. J Anal Toxicol 37(8):559–564. https://doi.org/10.1093/jat/bkt076
Patel NP, Sanyal M, Sharma N, Patel DS, Shrivastav PS, Patel BN (2018) Determination of asenapine in presence of its inactive metabolites in human plasma by LC-MS/MS. J Pharm Anal 8(5):341–347. https://doi.org/10.1016/j.jpha.2018.06.002
Patel RB, Naregalkar NS, Patel MR (2015) Stability-indicating HPTLC method for quantitative estimation of asenapine maleate in pharmaceutical formulations, equilibrium solubility, and ex vivo diffusion studies. J Liq Chrom Relat Tech 38(19):1731–1739. https://doi.org/10.1080/10826076.2015.1092448
Patteet L, Maudens KE, Sabbe B, Morrens M, De Doncker M, Neels H (2014) High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry. Clin Chim Acta 429:51–58. https://doi.org/10.1016/j.cca.2013.11.024
Protti M, Vignali A, Blanco TS, Rudge J, Bugamelli F, Ferranti A, Mandrioli R, Mercolini L (2018) Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection. J Sep Sci 41(6):1257–1265. https://doi.org/10.1002/jssc.201701315
Ramadan NK, Mohamed TA, Fouad RM, Moustafa AA (2017) Stability-indicating high-performance liquid chromatography and thin-layer chromatography methods for the determination of cyclobenzaprine hydrochloride and asenapine maleate. JPC-J Planar Chromat 30(4):313–322. https://doi.org/10.1556/1006.2017.30.4.12
Reddy AVB, Venugopal N, Madhavi G (2013) Simultaneous determination of asenapine and valproic acid in human plasma using LC–MS/MS: application of the method to support pharmacokinetic study. J Pharm Anal 3(6):394–401. https://doi.org/10.1016/j.jpha.2013.04.008
Sempio C, Morini L, Vignali C, Groppi A (2014) Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC-MS/MS: application on postmortem samples. J Chromatogr B Analyt Technol Biomed Life Sci 970:1–7. https://doi.org/10.1016/j.jchromb.2014.08.039
Sistik P, Urinovska R, Brozmanova H, Kacirova I, Silhan P, Lemr K (2016) Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication. Biomed Chromatogr 30(2):217–224. https://doi.org/10.1002/bmc.3538
Szabó ZI, Toth G, Voelgyi G, Komjati B, Hancu G, Szente L, Sohajda T, Beni S, Muntean DL, Noszal B (2016) Chiral separation of asenapine enantiomers by capillary electrophoresis and characterization of cyclodextrin complexes by NMR spectroscopy, mass spectrometry and molecular modeling. J Pharm Biomed Anal 117:398–404. https://doi.org/10.1016/j.jpba.2015.09.022
Volk DW, Lewis DA (2015) Schizophrenia A2 - Rosenberg, Roger N. In: Pascual JM (ed) Rosenberg's molecular and genetic basis of neurological and psychiatric disease. Academic Press, Boston, pp 1293–1299
Acknowledgements
Authors gratefully acknowledge the support of Research Council of Anadolu University for the funding of this study (Project No: 1302S023).
Funding
This work was supported by Research Council of Anadolu University (Project No: 1302S023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Aliyeva, S., Atila Karaca, S., Uğur, A. et al. A novel capillary electrophoresis method for the quantification of asenapine in pharmaceuticals using Box-Behnken design. Chem. Pap. 74, 4443–4451 (2020). https://doi.org/10.1007/s11696-020-01256-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-020-01256-5